Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 20, 2023. (Total: 58791 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 313 Records)

Next

Query Trace: Lung Cancer[original query]>>Reviews/Commentaries[Product Type]
Rare molecular subtypes of lung cancer.
Guilherme Harada et al. Nature reviews. Clinical oncology 2023
Liquid Biopsy for Guiding Treatment Decisions in Advanced Non-Small Cell Lung Cancer.
Gretchen Suk et al. Journal of the advanced practitioner in oncology 2023 13(8) 790-795
Integration of artificial intelligence in lung cancer: Rise of the machine.
Colton Ladbury et al. Cell reports. Medicine 2023 100933
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology].
Olivier Trédan et al. Bulletin du cancer 2023
Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
Britt Alec S et al. Frontiers in oncology 2022 12996554
Leveraging Artificial Intelligence to Improve Accuracy of Lung Cancer Screening
NCI Blog, December 16, 2022
Using Tree-Based Machine Learning for Health Studies: Literature Review and Case Series.
Hu Liangyuan et al. International journal of environmental research and public health 2022 19(23)
Artificial intelligence: A critical review of applications for lung nodule and lung cancer.
de Margerie-Mellon Constance et al. Diagnostic and interventional imaging 2022
Artificial intelligence in lung cancer: current applications and perspectives.
Chassagnon Guillaume et al. Japanese journal of radiology 2022
Using genomic profiling for understanding and improving response to smoking cessation treatment.
Bierut Laura J et al. Current epidemiology reports 2022 6(4) 486-490
The Potential Role of Artificial Intelligence in Lung Cancer Screening Using Low-Dose Computed Tomography.
Grenier Philippe A et al. Diagnostics (Basel, Switzerland) 2022 12(10)
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review.
Krebs Matthew G et al. JAMA oncology 2022
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
N Pujol et al, J Per Med, October 8, 2022
Artificial intelligence in lung cancer: Application and future thinking.
Zhao Wei et al. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2022 47(8) 994-1000
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
Penault-Llorca Frédérique et al. Virchows Archiv : an international journal of pathology 2022
A narrative review of deep learning applications in lung cancer research: from screening to prognostication.
Lee Jong Hyuk et al. Translational lung cancer research 2022 11(6) 1217-1229
Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment and prognosis.
Pei Qin et al. Clinical chemistry and laboratory medicine 2022
The application of artificial intelligence and radiomics in lung cancer.
Zhou Yaojie et al. Precision clinical medicine 2022 3(3) 214-227
Invited editorial: Q and A on hereditary lung cancer.
Benusiglio Patrick R et al. Respiratory medicine and research 2022 81100881
Precision Medicine Testing and Disparities in Health Care for Individuals With Non-Small Cell Lung Cancer: A Narrative Review.
Curtin Martha et al. Oncology nursing forum 2022 49(3) 257-272
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner.
Bontoux Christophe et al. Cancers 2022 14(7)
On the Automation of Radiomics-based Identification and Characterization of NSCLC.
D'Arnese Eleonora et al. IEEE journal of biomedical and health informatics 2022 PP
The application of artificial intelligence in lung cancer: a narrative review.
Zhang Huixian et al. Translational cancer research 2022 10(5) 2478-2487
Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations.
Guaitoli Giorgia et al. International journal of molecular sciences 2021 22(23)
Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force.
Lim Kiat Hon Tony et al. Asia-Pacific journal of clinical oncology 2021
Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
C D'Avella et al, JAMA Network Open, November 5, 2021
Deep Learning for Lung Cancer Nodal Staging and Real-World Clinical Practice.
Park Chang Min et al. Radiology 2021 211981
Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives.
Aleksakhina Svetlana N et al. International journal of molecular sciences 2021 22(20)
The impact of immune checkpoint inhibitors on cost and quality of life in the initial treatment of patients with advanced or metastatic NSCLC.
Procailo Kelly et al. The American journal of managed care 2021 27(18 Suppl) S333-S339
Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.
Tu Hai-Yan et al. Clinical lung cancer 2021
TOP